Back
Insmed Vs. Bioventus Industry Stock Comparison
Buy
71
INSM
Insmed
Last Price:
74.29
Seasonality Move:
7.17%
Buy
99
BVS
Bioventus
Last Price:
12.57
Seasonality Move:
7.37%
Buy
71
Insmed (INSM)
is a Buy
Is Insmed a Buy, Sell or Hold?
- The current Insmed [INSM] share price is $76.65. The Score for INSM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- INSM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
99
Bioventus (BVS)
is a Buy
Is Bioventus a Buy, Sell or Hold?
- The current Bioventus [BVS] share price is $12.92. The Score for BVS is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- BVS is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
INSM Stock Price Chart
INSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 61.18 | Buy |
Chaikin Money Flow: | 302955 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (71.56 - 74.58) | Buy |
Bollinger Bands (100): | (62.32 - 78.3) | Buy |
BVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.57 | Buy |
Relative Strength Index (14 RSI): | 69.11 | Buy |
Chaikin Money Flow: | 273098 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.16 - 12.16) | Buy |
Bollinger Bands (100): | (6.23 - 10.71) | Buy |
INSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 73.06 | Buy |
20-day SMA: | 72.94 | Buy |
50-day SMA: | 73.96 | Buy |
200-day SMA: | 48.74 | Buy |
8-day EMA: | 74.01 | Buy |
20-day EMA: | 73.32 | Buy |
50-day EMA: | 72.29 | Buy |
200-day EMA: | 54.67 | Buy |
BVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.98 | Buy |
20-day SMA: | 11.77 | Buy |
50-day SMA: | 10.38 | Buy |
200-day SMA: | 6.7 | Buy |
8-day EMA: | 12.23 | Buy |
20-day EMA: | 11.71 | Buy |
50-day EMA: | 10.49 | Buy |
200-day EMA: | 7.41 | Buy |
Insmed Earnings Growth & INSM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $1.08 per share.
Bioventus Earnings Growth & BVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.26 per share.
Insmed Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bioventus Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |